PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The overall goal of this research is to validate and develop a non-invasive imaging biomarker
of prostate cancer detection, progression, and recurrence. Development of such a biomarker
may be useful to differentiate indolent from aggressive prostate cancer phenotypes allowing
for selection of an appropriate risk adaptive therapy.